Vanguard Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $3.7M | Sell |
|
|||||
|
2023
Q4 | $2.38M | Buy |
|
|||||
|
2023
Q3 | $2.95M | Sell |
|
|||||
|
2023
Q2 | $7.23M | Sell |
|
|||||
|
2023
Q1 | $15M | Sell |
|
|||||
|
2022
Q4 | $22.5M | Buy |
|
|||||
|
2022
Q3 | $51M | Buy |
|
|||||
|
2022
Q2 | $43.6M | Buy |
|
|||||
|
2022
Q1 | $46M | Buy |
|
|||||
|
2021
Q4 | $52.5M | Buy |
|
|||||
|
2021
Q3 | $32.8M | Buy |
|
|||||
|
2021
Q2 | $27.4M | Sell |
|
|||||
|
2021
Q1 | $65.2M | Buy |
|
|||||
|
2020
Q4 | $53.2M | Buy |
|
|||||
|
2020
Q3 | $23M | Buy |
|
|||||
|
2020
Q2 | $27.8M | Buy |
|
|||||
|
2020
Q1 | $5.84M | Buy |
|
|||||
|
2019
Q4 | $8.5M | Buy |
|
|||||
|
2019
Q3 | $2.38M | Buy |
|
|||||
|
2019
Q2 | $2.46M | Buy |
|